Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-Induced Neutropenia|Myelosuppression|Breast Cancer
Interventions: DRUG: Myelo001|DRUG: Placebo
Sponsor: Myelo Therapeutics GmbH